- Home
- CLOV vs WGS Comparison
CLOV vs WGS Comparison
Compare CLOV & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- WGS
- Stock Information
- Founded
- CLOV 2014
- WGS 2017
- Country
- CLOV United States
- WGS United States
- Employees
- CLOV N/A
- WGS N/A
- Industry
- CLOV Medical Specialities
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- CLOV Health Care
- WGS Technology
- Exchange
- CLOV Nasdaq
- WGS Nasdaq
- Market Cap
- CLOV 1.8B
- WGS 2.0B
- IPO Year
- CLOV N/A
- WGS N/A
- Fundamental
- Price
- CLOV $4.57
- WGS $69.83
- Analyst Decision
- CLOV Buy
- WGS Strong Buy
- Analyst Count
- CLOV 2
- WGS 5
- Target Price
- CLOV $5.00
- WGS $80.60
- AVG Volume (30 Days)
- CLOV 7.1M
- WGS 852.3K
- Earning Date
- CLOV 03-11-2025
- WGS 02-18-2025
- Dividend Yield
- CLOV N/A
- WGS N/A
- EPS Growth
- CLOV N/A
- WGS N/A
- EPS
- CLOV N/A
- WGS N/A
- Revenue
- CLOV $2,115,219,999.00
- WGS $267,228,000.00
- Revenue This Year
- CLOV N/A
- WGS $43.70
- Revenue Next Year
- CLOV $13.05
- WGS $17.28
- P/E Ratio
- CLOV N/A
- WGS N/A
- Revenue Growth
- CLOV 13.50
- WGS 29.41
- 52 Week Low
- CLOV $0.61
- WGS $3.66
- 52 Week High
- CLOV $4.87
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- CLOV 65.60
- WGS 44.67
- Support Level
- CLOV $4.05
- WGS $68.33
- Resistance Level
- CLOV $4.87
- WGS $82.49
- Average True Range (ATR)
- CLOV 0.27
- WGS 5.58
- MACD
- CLOV -0.01
- WGS -0.74
- Stochastic Oscillator
- CLOV 63.96
- WGS 33.24
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.